Previous close | 33.62 |
Open | 34.73 |
Bid | 33.38 x 100 |
Ask | 33.45 x 100 |
Day's range | 33.17 - 34.83 |
52-week range | 17.53 - 59.84 |
Volume | |
Avg. volume | 911,217 |
Market cap | 2.562B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
PTC Therapeutics, Inc. ( NASDAQ:PTCT ) shareholders will have a reason to smile today, with the analysts making...
PTC Therapeutics ( NASDAQ:PTCT ) First Quarter 2024 Results Key Financial Results Revenue: US$210.1m (down 4.7% from 1Q...